Matrix metalloproteinase-2 (MMP-2) regulates astrocyte motility in connection with the actin cytoskeleton and integrins

GLIA

Volumn 54, Issue 4, 2006, Pages 272-284

  Ogier, Crystel ^a   Bernard, Anne ^a   Chollet, Anne Marie ^b   Le Diguardher, Thierry ^b   Hanessian, Stephen ^c   Charton, Gérard ^a   Khrestchatisky, Michel ^a   Rivera, Santiago ^a  

^a Mediterranée University   (France)

^b INSTITUT DE RECHERCHES INTERNATIONALES SERVIER   (France)

^c UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Brain; Gelatinolysis; Glia; In situ zymography; Migration; Proteinase inhibitor; TIMP

Indexed keywords

ACTIN; BB 3103; BETA1 INTEGRIN; CYTOCHALASIN D; GELATINASE A; GELATINASE B; ILOMASTAT; INTEGRIN; MATRIX METALLOPROTEINASE INHIBITOR;

ANIMAL TISSUE; ARTICLE; ASTROCYTE; CELL MIGRATION; CELL MOTILITY; CONTROLLED STUDY; CYTOSKELETON; DRUG EFFECT; DRUG INHIBITION; FEMALE; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; ZYMOGRAPHY;

ACTINS; ANIMALS; ANTIGENS, CD29; ASTROCYTES; CELL ADHESION; CELL MOVEMENT; CELL PROLIFERATION; CYTOSKELETON; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; GELATINASES; IMMUNOHISTOCHEMISTRY; INTEGRINS; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MICE; PROTEASE INHIBITORS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEPHAROSE; THYMIDINE;

EID: 33748139021     PISSN: 08941491     EISSN: 10981136     Source Type: Journal    
DOI: 10.1002/glia.20349     Document Type: Article

References (71)

1. Akahane T, Akahane M, Shah A, Connor CM, Thorgeirsson UP. 2004. TIMP-1 inhibits microvascular endothelial cell migration by MMP-dependent and MMP-independent mechanisms. Exp Cell Res 301:158-167.
2. Alfano D, Franco P, Vocca I, Gambi N, Pisa V, Mancini A, Caputi M, Carriero MV, Iaccarino I, Stoppelli MP. 2005. The urokinase plasminogen activator and its receptor: Role in cell growth and apoptosis. Thromb Haemost 93:205-211.
3. Apparailly F, Noel D, Millet V, Baker AH, Lisignoli G, Jacquet C, Kaiser MJ, Sany J, Jorgensen C. 2001. Paradoxical effects of tissue inhibitor of metalloproteinases 1 gene transfer in collagen-induced arthritis. Arthritis Rheum 44:1444-1454.
4. Ayoub AE, Cai TQ, Kaplan RA, Luo J. 2005. Developmental expression of matrix metalloproteinases 2 and 9 and their potential role in the histogenesis of the cerebellar cortex. J Comp Neurol 481:403-415.
5. Behrendtsen O, Werb Z. 1997. Metalloproteinases regulate parietal endoderm differentiating and migrating in cultured mouse embryos. Dev Dyn 208:255-265.
6. Brooks PC, Strömblad S, Sanders LC, von Schalscha TL, Aimes RT, Stetler-Stevenson WG, Quigley JP, Cheresh DA. 1996. Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin αvβ3. Cell 85:683-693.
7. Buisson-Legendre N, Bernard P, Bobichon H, Emonard H, Schneider C, Maquart FX, Haye B, Hornebeck W. 1999. Involvement of the 92-kDa gelatinase (matrix metalloproteinase-9) in the ceramide-mediated inhibition of human keratinocyte growth. Biochem Biophys Res Commun 260:634-640.
8. Chollet AM, Le Diguarher T, Kucharczyk N, Loynel A, Bertrand M, Tucker G, Guilbaud N, Burbridge M, Pastoureau P, Fradin A, Sabatini M, Fauchere JL, Casara P. 2002. Solid-phase synthesis of alpha-substituted 3-bisarylthio N-hydroxy propionamides as specific MMP inhibitors. Bioorg Med Chem 10:531-544.
9. Coker ML, Doscher MA, Thomas CV, Galis ZS, Spinale FG. 1999. Matrix metalloproteinase synthesis and expression in isolated LV myocyte preparations. Am J Physiol 277(Pt 2):H777-H787.
10. Cullen JP, Nicholl SM, Sayeed S, Sitzmann JV, Okada SS, Cahill PA, Redmond EM. 2004. Plasminogen activator inhibitor-1 deficiency enhances flow-induced smooth muscle cell migration. Thromb Res 114:57-65.
11. Denhardt DT, Feng B, Edwards DR, Cocuzzi ET, Malyankar UM. 1993. Tissue inhibitor of metalloproteinases (TIMP, aka EPA): Structure, control of expression and biological functions. Pharmacol Ther 59:329-341.
12. Deryugina EI, Bourdon MA, Luo GX, Reisfeld RA, Strongin A. 1997. Matrix metalloproteinase-2 activation modulates glioma cell migration. J Cell Sci 110(Pt 19):2473-2482.
13. Deryugina EI, Ratnikov BI, Strongin AY. 2003. Prinomastat, a hydroxamate inhibitor of matrix metalloproteinases, has a complex effect on migration of breast carcinoma cells. Int J Cancer 104:533-541.
14. Dong Y, Benveniste EN. 2001. Immune function of astrocytes. Glia 36:180-190.
15. Edwards DR, Beaudry PP, Laing TD, Kowal V, Leco KJ, Leco PA, Lim MS. 1996. The roles of tissue inhibitors of metalloproteinases in tissue remodelling and cell growth. Int J Obes Relat Metab Disord 20(Suppl 3):S9-S15.
16. Engsig MT, Chen QJ, Vu TH, Pedersen AC, Therkidsen B, Lund LR, Henriksen K, Lenhard T, Foged NT, Werb Z, Delaisse JM. 2000. Matrix metalloproteinase 9 and vascular endothelial growth factor are essential for osteoclast recruitment into developing long bones. J Cell Biol 151:879-889.
17. Friedl P. 2004. Prespecification and plasticity: Shifting mechanisms of cell migration. Curr Opin Cell Biol 16:14-23.
18. Friedl P, Wolf K. 2003. Tumour-cell invasion and migration: Diversity and escape mechanisms. Nat Rev Cancer 3:362-374.
19. Gomez DE, Alonso DF, Yoshiji H, Thorgeirsson UP. 1997. Tissue inhibitors of metalloproteinases: Structure, regulation and biological functions. Eur J Cell Biol 74:111-122.
20. Graesser D, Mahooti S, Madri JA. 2000. Distinct roles for matrix metalloproteinase-2 and alpha4 integrin in autoimmune T cell extravasation and residency in brain parenchyma during experimental autoimmune encephalomyelitis. J Neuroimmunol 109:121-131.
21. Gravanis I, Tsirka SE. 2005. Tissue plasminogen activator and glial function. Glia 49:177-183.
22. Hanessian S, Moitessier N, Gauchet C, Viau M. 2001. N-Aryl sulfonyl homocysteine hydroxamate inhibitors of matrix metalloproteinases: Further probing of the S(1), S(1)′, and S(2)′ pockets. J Med Chem 44:3066-3073.
23. Hirsch MS, Law LY, Trinkaus-Randall V, Svoboda KK. 1994. The intracellular distribution of vinculin and alpha 2 integrin in epithelial cells and chondrocytes. Scanning 16:275-284.
24. Hoashi T, Kadono T, Kikuchi K, Etoh T, Tamaki K. 2001. Differential growth regulation in human melanoma cell lines by TIMP-1 and TIMP-2. Biochem Biophys Res Commun 288:371-379.
25. Hotary K, Allen E, Punturieri A, Yana I, Weiss SJ. 2000. Regulation of cell invasion and morphogenesis in a three-dimensional type I collagen matrix by membrane-type matrix metalloproteinases 1, 2, and 3. J Cell Biol 149:1309-1323.
26. Jaworski DM. 2000. Differential regulation of tissue inhibitor of metalloproteinase mRNA expression in response to intracranial injury. Glia 30:199-208.
27. Jourquin J, Tremblay E, Decanis N, Charton G, Hanessian S, Chollet AM, Le Diguardher T, Khrestchatisky M, Rivera S. 2003. Neuronal activity-dependent increase of net matrix metalloproteinase activity is associated with MMP-9 neurotoxicity after kainate. Eur J Neurosci 18:1507-1517.
28. Kajita M, Itoh Y, Chiba T, Mori H, Okada A, Kinoh H, Seiki M. 2001. Membrane-type 1 matrix metalloproteinase cleaves CD44 and promotes cell migration. J Cell Biol 153:893-904.
29. Le DM, Besson A, Fogg DK, Choi KS, Waisman DM, Goodyer CG, Rewcastle B, Yong VW. 2003. Exploitation of astrocytes by glioma cells to facilitate invasiveness: A mechanism involving matrix metalloproteinase-2 and the urokinase-type plasminogen activator-plasmin cascade. J Neurosci 23:4034-4043.
30. Lee WJ, Shin CY, Yoo BK, Ryu JR, Choi EY, Cheong JH, Ryu JH, Ko KH. 2003. Induction of matrix metalloproteinase-9 (MMP-9) in lipopolysaccharide- stimulated primary astrocytes is mediated by extracellular signal-regulated protein kinase 1/2 (Erk1/2). Glia 41:15-24.
31. Leveque T, Le Pavec G, Boutet A, Tardieu M, Dormont D, Gras G. 2004. Differential regulation of gelatinase A, B and TIMP-1 and -2 by TNFalpha and HIV virions in astrocytes. Microbes Infect 6:157-163.
32. Levkau B, Kenagy RD, Karsan A, Weitkamp B, Clowes AW, Ross R, Raines EW. 2002. Activation of metalloproteinases and their association with integrins: An auxiliary apoptotic pathway in human endothelial cells. Cell Death Differ 9:1360-1367.
33. Makela M, Larjava H, Pirila E, Maisi P, Salo T, Sorsa T, Uitto VJ. 1999. Matrix metalloproteinase 2 (gelatinase A) is related to migration of keratinocytes. Exp Cell Res 251:67-78.
34. Mannello F, Gazzanelli G. 2001. Tissue inhibitors of metalloproteinases and programmed cell death: Conundrums, controversies and potential implications. Apoptosis 6:479-482.
35. Martin J, Eynstone LV, Davies M, Williams JD, Steadman R. 2002. The role of ADAM 15 in glomerular mesangial cell migration. J Biol Chem 277:33683-33689.
36. Milner R, Campbell IL. 2002. The integrin family of cell adhesion molecules has multiple functions within the CNS. J Neurosci Res 69:286-291.
37. Milner R, Huang X, Wu J, Nishimura S, Pytela R, Sheppard D, ffrench-Constant C. 1999. Distinct roles for astrocyte alphavbeta5 and alphavbeta8 integrins in adhesion and migration. J Cell Sci 112(Pt 23):4271-4279.
38. Mitra A, Chakrabarti J, Banerji A, Chatterjee A. 2004. Binding of alpha2 monoclonal antibody to human cervical tumor cell (SiHa) surface alpha2beta1 integrin modulates MMP-2 activity. Gynecol Oncol 94:33-39.
39. Mitra A, Chakrabarti J, Chatterjee A. 2003. Binding of alpha5 monoclonal antibody to cell surface alpha5beta1 integrin modulates MMP-2 and MMP-7 activity in B16F10 melanoma cells. J Environ Pathol Toxicol Oncol 22:167-178.
40. Montuori N, Visconte V, Rossi G, Ragno P. 2005. Soluble and cleaved forms of the urokinase-receptor: Degradation products or active molecules? Thromb Haemost 93:192-198.
41. Mosmann T. 1983. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J Immunol Methods 65(1/2):55-63.
42. Muir EM, Adcock KH, Morgenstern DA, Clayton R, von Stillfried N, Rhodes K, Ellis C, Fawcett JW, Rogers JH. 2002. Matrix metalloproteases and their inhibitors are produced by overlapping populations of activated astrocytes. Brain Res Mol Brain Res 100(1/2):103-117.
43. Nagashima G, Suzuki R, Asai J, Fujimoto T. 2002. Immunohistochemical analysis of reactive astrocytes around glioblastoma: An immunohistochemical study of postmortem glioblastoma cases. Clin Neurol Neurosurg 104:125-131.
44. O'Connell JP, Willenbrock F, Docherty AJ, Eaton D, Murphy G. 1994. Analysis of the role of the COOH-terminal domain in the activation, proteolytic activity, and tissue inhibitor of metalloproteinase interactions of gelatinase B. J Biol Chem 269:14967-14973.
45. Ogier C, Creidy C, Boucraut J, Soloway S, Khrestchatisky M, Rivera S. 2005. Astrocyte reactivity to Fas activation is attenuated in TIMP-1 deficient mice: An in vitro study. BMC Neuroscience 6:68.
46. Owen CA, Hu Z, Barrick B, Shapiro SD. 2003. Inducible expression of tissue inhibitor of metalloproteinases-resistant matrix metalloproteinase-9 on the cell surface of neutrophils. Am J Respir Cell Mol Biol 29(Pt 1):283-294.
47. Pagenstecher A, Stalder AK, Kincaid CL, Shapiro SD, Campbell IL. 1998. Differential expression of matrix metalloproteinase and tissue inhibitor of matrix metalloproteinase genes in the mouse central nervous system in normal and inflammatory states. Am J Pathol 152:729-741.
48. Park DW, Ryu HS, Choi DS, Park YH, Chang KH, Min CK. 2001. Localization of matrix metalloproteinases on endometrial cancer cell invasion in vitro. Gynecol Oncol 82:442-449.
49. Pilcher BK, Dumin JA, Sudbeck BD, Krane SM, Welgus HG, Parks WC. 1997. The activity of collagenase-1 is required for keratinocyte migration on a type I collagen matrix. J Cell Biol 137:1445-1457.
50. Porter JF, Shen S, Denhardt DT. 2004. Tissue inhibitor of metalloproteinase-1 stimulates proliferation of human cancer cells by inhibiting a metalloproteinase. Br J Cancer 90:463-470.
51. Rathke-Hartlieb S, Budde P, Ewert S, Schlomann U, Staege MS, Jockusch H, Bartsch JW, Frey J. 2000. Elevated expression of membrane type 1 metalloproteinase (MT1-MMP) in reactive astrocytes following neurodegeneration in mouse central nervous system. FEBS Lett 481:227-234.
52. Ridet JL, Malhotra SK, Privat A, Gage FH. 1997. Reactive astrocytes: Cellular and molecular cues to biological function. Trends Neurosci 20:570-577.
53. Rivera, Ogier C, Jourquin J, Timsit S, Szklarczyk A, Miller K, Gearing A, Kaczmarek L, Khrestchatisky M. 2002. Gelatinase B, TIMP-1 are regulated in a cell- and time dependent manner in association with neuronal death and glial reactivity after global forebrain ischemia. Eur J Neurosci 15:19-32.
54. Rivera S, Khrestchatisky M. 1999. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in neuronal plasticity and pathology. In: Baudry M, Thomsom RF, Davis JL, editors. Advances in synaptic plasticity. Cambridge, Massachusetts: The MIT Press. pp 53-86.
55. Rivera S, Tremblay E, Timsit S, Canals O, Ben-Ari Y, Khrestchatisky M. 1997. Tissue inhibitor of metalloproteinases-1 (TIMP-1) is differentially induced in neurons and astrocytes after seizures: Evidence for developmental, immediate early gene, and lesion response. J Neurosci 17:4223-4235.
56. Roeb E, Bosserhoff AK, Hamacher S, Jansen B, Dahmen J, Wagner S, Matern S. 2005. Enhanced migration of tissue inhibitor of metalloproteinase overexpressing hepatoma cells is attributed to gelatinases: Relevance to intracellular signaling pathways. World J Gastroenterol 11:1096-1104.
57. Rosenberg GA, Cunningham LA, Wallace J, Alexander S, Estrada EY, Grossetete M, Razhagi A, Miller K, Gearing A. 2001. Immunohistochemistry of matrix metalloproteinases in reperfusion injury to rat brain: Activation of MMP-9 linked to stromelysin-1 and microglia in cell cultures. Brain Res 893(1/2):104-112.
58. Seiki M, Mori H, Kajita M, Uekita T, Itoh Y. 2003. Membrane-type 1 matrix metalloproteinase and cell migration. Biochem Soc Symp 70:253-262.
59. Sternlicht MD, Werb Z. 2001. How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol 17:463-516.
60. Suetsugu S, Yamazaki D, Kurisu S, Takenawa T. 2003. Differential roles of WAVE1 and WAVE2 in dorsal and peripheral ruffle formation for fibroblast cell migration. Dev Cell 5:595-609.
61. Szklarczyk A, Lapinska J, Rylski M, McKay RD, Kaczmarek L. 2002. Matrix metalloproteinase-9 undergoes expression and activation during dendritic remodeling in adult hippocampus. J Neurosci 22:920-930.
62. Takino T, Miyamori H, Watanabe Y, Yoshioka K, Seiki M, Sato H. 2004. Membrane type 1 matrix metalloproteinase regulates collagen-dependent mitogen-activated protein/extracellular signal-related kinase activation and cell migration. Cancer Res 64:1044-1049.
63. Tomasek JJ, Halliday NL, Updike DL, Ahern-Moore JS, Vu TK, Liu RW, Howard EW. 1997. Gelatinase A activation is regulated by the organization of the polymerized actin cytoskeleton. J Biol Chem 272:7482-7487.
64. Upadhyay J, Shekarriz B, Nemeth JA, Dong Z, Cummings GD, Fridman R, Sakr W, Grignon DJ, Cher ML. 1999. Membrane type 1-matrix metalloproteinase (MT1-MMP) and MMP-2 immunolocalization in human prostate: Change in cellular localization associated with high-grade prostatic intraepithelial neoplasia. Clin Cancer Res 5:4105-4110.
65. Vaillant C, Didier-Bazes M, Hutter A, Belin MF, Thomasset N. 1999. Spatiotemporal expression patterns of metalloproteinases and their inhibitors in the postnatal developing rat cerebellum. J Neurosci 19:4994-5004.
66. Vaillant C, Meissirel C, Mutin M, Belin MF, Lund LR, Thomasset N. 2003. MMP-9 deficiency affects axonal outgrowth, migration, and apoptosis in the developing cerebellum. Mol Cell Neurosci 24:395-408.
67. Varani J, Orr W, Ward PA. 1978. A comparison of the migration patterns of normal and malignant cells in two assay systems. Am J Pathol 90:159-171.
68. Whittaker M, Floyd CD, Brown P, Gearing AJ. 1999. Design and therapeutic application of matrix metalloproteinase inhibitors. Chem Rev 99:2735-2776.
69. Yong VW, Power C, Forsyth P, Edwards DR. 2001. Metalloproteinases in biology and pathology of the nervous system. Nat Rev Neurosci 2:502-511.
70. Zigrino P, Drescher C, Mauch C. 2001. Collagen-induced proMMP-2 activation by MT1-MMP in human dermal fibroblasts and the possible role of alpha2beta1 integrins. Eur J Cell Biol 80:68-77.
71. Zuo J, Ferguson TA, Hernandez YJ, Stetler-Stevenson WG, Muir D. 1998. Neuronal matrix metalloproteinase-2 degrades and inactivates a neurite-inhibiting chondroitin sulfate proteoglycan. J Neurosci 18:5203-5211.